Why did Kyverna's operating expenses surge in Q4 2024?

Kyverna Therapeutics, Inc. (KYTX) did not experience a surge in operating expenses in Q4 2024. In fact, the latest report period for KYTX is for Q4 2024. Furthermore, no information regarding a surge in operating expenses was found in the search results.

However, it is important to note that Kyverna Therapeutics has been involved in a class action lawsuit related to its initial public offering (IPO) in February 2024. The lawsuits allege that Kyverna Therapeutics made false and misleading statements in its IPO documents about the company's performance and prospects, and that they failed to disclose certain risks associated with their business. It is possible that some of the expenses related to these lawsuits may have been recognized in Kyverna Therapeutics' financial statements for Q4 2024 or subsequent periods.